Latest Safety News

Page 9 of 144
Altech Batteries has completed the final design of its next-generation Sodium Nickel Chloride UPS battery system, setting the stage for factory testing and trial deployments across the Netherlands. This milestone marks a significant step toward broader European commercialisation.
Victor Sage
Victor Sage
27 Nov 2025
Imugene Limited and JW Therapeutics have launched a strategic collaboration to combine oncolytic virus and CAR-T cell therapies, aiming to tackle refractory solid tumors through a pioneering 'mark and kill' approach.
Ada Torres
Ada Torres
27 Nov 2025
Advanced Innergy Holdings Ltd (ASX, AIH) reported unaudited proforma FY25 results exceeding prospectus forecasts, driven by strong organic growth and the strategic acquisition of Ovun. The company reaffirms its FY26 guidance, supported by a robust orderbook and pipeline.
Victor Sage
Victor Sage
27 Nov 2025
Theta Gold Mines reports steady progress on its TGME Gold Project with key civil works milestones achieved, keeping the project on schedule for commissioning by the end of 2026.
Maxwell Dee
Maxwell Dee
27 Nov 2025
Critical Resources Limited has significantly expanded its Mavis Lake Lithium Project in Ontario, boosting its landholding by 25% and advancing exploration with promising high-grade lithium intercepts. The company also secured a strategic partnership to evaluate cutting-edge solid-state lithium-ion battery technology, positioning itself for the anticipated lithium market rebound.
Maxwell Dee
Maxwell Dee
27 Nov 2025
Provaris Energy’s 2025 AGM highlights strategic progress in hydrogen and CO2 storage technologies, focusing on European market expansion and a refined licensing business model.
Maxwell Dee
Maxwell Dee
27 Nov 2025
Element 25 Limited has announced significant progress in expanding its Butcherbird manganese mine and developing a US-based high-purity manganese refinery, backed by substantial government grants and strategic partnerships with automotive giants.
Maxwell Dee
Maxwell Dee
26 Nov 2025
InhaleRx Limited has introduced SRX-25, an oral fixed-dose combination therapy targeting Treatment-Resistant Depression, aiming to improve patient access and adherence. The company also secured $1 million in capital to advance clinical development and plans a strategic rebrand.
Ada Torres
Ada Torres
26 Nov 2025
Recce Pharmaceuticals has reported compelling preclinical results for its inhaled anti-infective RECCE 327, demonstrating potent activity against multidrug-resistant pneumonia bacteria in mice models.
Ada Torres
Ada Torres
26 Nov 2025
Race Oncology has received ethics approval to launch its HARNESS-1 Phase 1a/b trial testing RC220 combined with osimertinib in EGFR-mutated non-small cell lung cancer patients, marking a key step toward addressing resistance to current therapies.
Ada Torres
Ada Torres
26 Nov 2025
Patrys Limited has expanded its clinical pipeline by acquiring Reliis Pty Ltd, gaining a proprietary injectable formulation of Quetiapine aimed at the large and underserved delirium market. This strategic move balances Patrys’ portfolio with a near-term pharmaceutical asset alongside its biologics program.
Ada Torres
Ada Torres
26 Nov 2025
Select Harvests Limited reported a robust FY2025 with a 32.4% almond price surge driving a $30.9 million NPAT increase and halving net debt. The company’s strategic investments and operational efficiencies position it well for a positive FY2026 outlook.
Ada Torres
Ada Torres
26 Nov 2025